Treatments for Hemophilia

Below is a listing of treatments and therapies for hemophilia. Click on one to read more information or connect with others currently using it.

View:
  • Advate (Antihemophilic factor [recombinant])

    Overview
    Advate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Advate can also be used fo... read more

  • Adynovate (Antihemophilic factor [recombinant], PEGylated)

    Overview
    Adynovate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in adults and adolescents over the age of 12 with factor VIII deficiency due to hemophilia A. A... read more

  • Afstyla (Antihemophilic factor [recombinant], single chain)

    Overview
    Afstyla is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Afstyla can also be used ... read more

  • Alphanate (Antihemophilic factor/von Willebrand factor complex [human])

    Overview
    Alphanate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Alphanate is also used ... read more

  • AlphaNine SD (Coagulation factor IX [human])

    Overview
    AlphaNine SD is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of AlphaNine SD is Coagulation factor IX factor (huma... read more

  • Alprolix (Coagulation factor IX [recombinant], Fc fusion protein)

    Overview
    Alprolix is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. Alprolix can also be used for perioperative (before, d... read more

  • Amicar (Aminocaproic acid)

    Overview
    Amicar is approved by the Food and Drug Administration (FDA) to stop bleeding. Amicar may be used during heart surgery and for bleeding disorders such as hemophilia. Amicar is also known by its drug n... read more

  • Bebulin (Factor IX complex [human])

    Overview
    Bebulin is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Bebulin is Factor IX complex (human).

    Bebulin is a ... read more

  • BeneFix (Coagulation factor IX [recombinant])

    Overview
    BeneFix is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. BeneFix can also be used for perioperative (before, dur... read more

  • Central venous access devices

    Overview
    People with hemophilia who have developed inhibitors may need frequent or urgent doses of intravenous medications, especially while undergoing immune tolerance therapy. Some people choose to have a ce... read more

  • Clinical Trials

    Overview
    Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for hemophilia. Eligibility may be based on specifics of your condition, such as which clott... read more

  • Cyklokapron (Tranexamic acid)

    Overview
    Cyklokapron is approved by the Food and Drug Administration (FDA) for short-term use in people with hemophilia. Cyklokapron may be used for two to eight days to reduce or prevent hemorrhage during and... read more

  • Eloctate (Antihemophilic factor [recombinant], Fc fusion protein)

    Overview
    Eloctate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Eloctate can also be use... read more

  • Exercise

    Overview
    Exercise can strengthen your muscles, help protect your joints, and lower your risk for bleeds. Exercise can improve your flexibility and decrease stiffness. Better fitness can help improve balance an... read more

  • Feiba (Anti-inhibitor coagulant complex)

    Overview
    Feiba is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in people with hemophilia A and B who have developed inhibitors. Feiba can also be used for perioperative (b... read more

  • Helixate FS (Antihemophilic factor [recombinant], formulated with sucrose)

    Overview
    Helixate FS is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Helixate FS can also be used for perioperative (bef... read more

  • Hepatitis vaccinations

    Overview
    It is strongly recommended that everyone with a bleeding disorder such as hemophilia receive vaccinations for Hepatitis A and Hepatitis B.

    What does it involve?
    Both Hepatitis A and Hepati... read more

  • Humate-P (Antihemophilic factor/von Willebrand factor complex [human])

    Overview
    Humate-P is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Humate-P is also used to treat bleeding episodes and for perioperative (befo... read more

  • Idelvion (Coagulation factor IX [recombinant], albumin fusion protein)

    Overview
    Idelvion is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor IX deficiency due to hemophilia B. Idelvion can also be used ... read more

  • Immune tolerance therapy (ITT)

    Overview
    Immune tolerance therapy (ITT) involves infusing clotting factor concentrate in scheduled doses to train the body to tolerate the factor. The goal of ITT is to eradicate the inhibitor.

    What does it... read more

  • Joint wraps (Joint wraps)

    Overview

    Joint bleeds carry the risks of pain, long-term damage, and even disability. Wrapping a bleeding joint reduces blood flow using compression and possibly cold.

    What does it involve?
    There are ma... read more

  • Koate-DVI (Antihemophilic factor [human])

    Overview
    Koate-DVI is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Koate-DVI can also be used for perioperative (before, during, and after sur... read more

  • Kogenate FS (Antihemophilic factor [recombinant])

    Overview
    Kogenate FS is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Kogenate FS can also ... read more

  • Konyne 80 (Factor IX complex [human)

    Overview
    Konyne 80 is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. Konyne 80 may also be used to reverse coumarin anticoagulant-induced hemorr... read more

  • Kovaltry (Antihemophilic factor [recombinant])

    Overview
    Kovaltry is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Kovaltry can also be use... read more

  • Mononine (Coagulation factor IX [human])

    Overview
    Mononine is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Mononine is Coagulation factor IX factor (human).

    ... read more

  • Novoeight (Antihemophilic factor [recombinant])

    Overview
    Novoeight is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Novoeight can also be used for perioperative (before,... read more

  • NovoSeven RT (Coagulation factor VIIa [recombinant])

    Overview
    NovoSeven RT is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A or B. Typically, Novo... read more

  • Nuwiq (Human coagulation factor VIII [rDNA], simoctocog alfa)

    Overview
    Nuwiq is approved by the Food and Drug Administration (FDA) to treat and prevent bleeding episodes in children and adults with hemophilia A (congenital factor VIII deficiency). The technical name of N... read more

  • Obizur (Antihemophilic factor [Recombinant], porcine sequence)

    Overview
    Obizur is approved by the Food and Drug Administration (FDA) to control bleeding episodes in adults with acquired hemophilia. The technical name of Obizur is Antihemophilic factor (recombinant), porci... read more

  • Physical Therapy

    Overview
    Physical therapy can help keep your joints and muscles working properly. Physical therapy can also rehabilitate joints after a bleed. Better fitness can help improve balance and strength and cut down ... read more

  • Profilnine (Factor IX complex [human])

    Overview
    Profilnine is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Profilnine is Factor IX complex (human).

    Profiln... read more

  • Proplex-T (Factor IX complex, heat treated [human])

    Overview
    Proplex-T is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. Proplex-T may also be used for perioperative (before, during, and after sur... read more

  • Recombinate (Antihemophilic factor [recombinant])

    Overview
    Recombinate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Recombinate can also be used for perioperative (bef... read more

  • ReFacto (Antihemophilic factor [recombinant])

    Overview
    ReFacto is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. ReFacto can also be used for perioperative (before, dur... read more

  • Rixubis (Coagulation factor IX [recombinant])

    Overview
    Rixubis is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. Rixubis can also be used for perioperative (before, dur... read more

  • Stimate (Desmopressin)

    Overview
    Stimate is approved by the Food and Drug Administration (FDA) to stop bleeding episodes in children and adults with mild hemophilia A or mild to moderate von Willebrand’s Disease. Stimate is also know... read more

  • Vonvendi (von Willebrand factor [recombinant])

    Overview
    Vonvendi is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in adults with von Willebrand disease. The technical name of Vonvendi is von Wil... read more

  • Wilate (von Willebrand factor/Coagulation factor VIII complex [human])

    Overview
    Wilate is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in children and adults with von Willebrand disease. Wilate can also be used for pe... read more

  • Xyntha (Antihemophilic factor [recombinant])

    Overview
    Xyntha is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Xyntha can also be used for perioperative (before, durin... read more

MyHemophiliaTeam is a free social network that makes it easy to find others like you and gain insights from others living with hemophilia.
Sign up Log in